Stocks / MRNA / Net Income

Moderna, Inc. Net Income 2016–2025

Moderna, Inc. reported $-2.82B of net income for fiscal 2025. That was 20.8% higher than fiscal 2024. Compared with fiscal 2020, the change was -277.8%.

Latest filed value
$-2.82B
One-year change
+20.8%
Change since 2020
-277.8%
Latest period end
2025
Moderna, Inc. Net Income history from 2016 to 2025FY 2016: -216211000FY 2017: -255916000FY 2018: -384734000FY 2019: -514000000FY 2020: -747000000FY 2021: 12202000000FY 2022: 8362000000FY 2023: -4714000000FY 2024: -3561000000FY 2025: -2822000000
Annual filed history. Hover chart points for raw values; the accessible table below is the source of record.
Fiscal yearNet IncomeNet marginChange (YoY)
FY 2025$-2.82B-145.2%+20.8%
FY 2024$-3.56B-110.0%+24.5%
FY 2023$-4.71B-68.8%-156.4%
FY 2022$8.36B43.4%-31.5%
FY 2021$12.20B66.1%+1733.5%
FY 2020$-747.00M-93.0%-45.3%
FY 2019$-514.00M-856.7%-33.6%
FY 2018$-384.73M-284.8%-50.3%
FY 2017$-255.92M-124.3%-18.4%
FY 2016$-216.21M-199.5%

Source: Moderna, Inc. SEC filings — income statement (10-K). Computed deterministically; refreshed nightly (last updated August 2, 2026). Open MRNA 10-K filings at SEC EDGAR · Methodology · Download CSV.

How to read this history

Moderna, Inc. reported $-2.82B of net income for fiscal 2025. That was 20.8% higher than fiscal 2024. Compared with fiscal 2020, the change was -277.8%. Values remain missing when the cached filing does not disclose a comparable line item; they are never estimated. Stock splits, reorganizations and fiscal-calendar changes can reduce comparability.

Prepared and reviewed by the stockportfolio.pro research desk. Corrections: support@stockportfolio.pro.

See the full picture for Moderna, Inc.

Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.

Open the interactive view — free

Moderna, Inc. — frequently asked questions

What is Moderna, Inc.'s net income?

Moderna, Inc. (MRNA) reported net income of $-2.82B for fiscal year 2025, per its SEC filings.

Where does this data come from?

Figures are computed from Moderna, Inc.'s official SEC filings (income statement (10-K)), refreshed nightly. Not investment advice.

More MRNA financial history

Full MRNA fundamentals page → · Analyze net income with a free tool → · All 1,500+ companies →